{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:24:23Z","timestamp":1768278263488,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 NS070289"],"award-info":[{"award-number":["R01 NS070289"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03 CA102031"],"award-info":[{"award-number":["R03 CA102031"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Russian Fund of Fundamental Research","award":["11 411.0008700. 13.082"],"award-info":[{"award-number":["11 411.0008700. 13.082"]}]},{"name":"Russian Fund of Fundamental Research","award":["13\u00a0411. 1008799.13.120"],"award-info":[{"award-number":["13\u00a0411. 1008799.13.120"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.canlet.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T23:31:16Z","timestamp":1433547076000},"page":"240-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo"],"prefix":"10.1016","volume":"365","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-0363","authenticated-orcid":false,"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton V.","family":"Borovjagin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Kaverina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nameeta","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biaoyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Baryshnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Cobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.06.002_bib0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/hum.2006.17.556","article-title":"CD46 represents a target for adenoviral gene therapy of malignant glioma","volume":"17","author":"Ulasov","year":"2006","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000085575","article-title":"The role of radio- and chemotherapy in glioblastoma","volume":"28","author":"Stupp","year":"2005","journal-title":"Onkologie"},{"key":"10.1016\/j.canlet.2015.06.002_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2009.04.045","article-title":"Virotherapy against malignant glioma stem cells","volume":"289","author":"Dey","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.06.002_bib0025","first-page":"37","article-title":"Gelatinase-mediated migration and invasion of cancer cells","volume":"1755","author":"Bjorklund","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2015.06.002_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2004.03.008","article-title":"(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis","volume":"210","author":"Yamakawa","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.06.002_bib0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mc.20541","article-title":"Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling","volume":"48","author":"Annabi","year":"2009","journal-title":"Mol. Carcinog"},{"key":"10.1016\/j.canlet.2015.06.002_bib0040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cell.2013.11.019","article-title":"Autophagy-mediated tumor promotion","volume":"155","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.06.002_bib0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/cam4.104","article-title":"Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas","volume":"2","author":"Ulasov","year":"2013","journal-title":"Cancer Med"},{"key":"10.1016\/j.canlet.2015.06.002_bib0050","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1074\/jbc.M610894200","article-title":"MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival","volume":"282","author":"Currie","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.06.002_bib0055","first-page":"501","article-title":"Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells","volume":"15","author":"Wu","year":"2006","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2015.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jgm.1385","article-title":"A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy","volume":"11","author":"Nandi","year":"2009","journal-title":"J. Gene Med"},{"key":"10.1016\/j.canlet.2015.06.002_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.cgt.7701010","article-title":"Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients","volume":"14","author":"Brouwer","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0070","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3892\/ijo.2012.1674","article-title":"A novel Ad5\/11 chimeric oncolytic adenovirus for improved glioma therapy","volume":"41","author":"Li","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0075","first-page":"237","article-title":"Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo","volume":"27","author":"Zhu","year":"2005","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0080","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1128\/AAC.01126-12","article-title":"Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression","volume":"56","author":"Leung","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.canlet.2015.06.002_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cytogfr.2010.02.014","article-title":"Impact of tumor microenvironment on oncolytic viral therapy","volume":"21","author":"Wojton","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.canlet.2015.06.002_bib0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/mt.2008.63","article-title":"Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus","volume":"16","author":"Kang","year":"2008","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0095","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JVI.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J. Virol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0100","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2015.06.002_bib0105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jmb.2008.08.054","article-title":"Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid","volume":"383","author":"San Martin","year":"2008","journal-title":"J. Mol. Biol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat. Med"},{"key":"10.1016\/j.canlet.2015.06.002_bib0115","first-page":"1319","article-title":"Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma","volume":"29","author":"Zhu","year":"2006","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0120","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1158\/0008-5472.CAN-05-1871","article-title":"Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region","volume":"65","author":"Ono","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.06.002_bib0125","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.18632\/oncotarget.2897","article-title":"Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy","volume":"28","author":"Ulasov","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2015.06.002_bib0130","doi-asserted-by":"crossref","first-page":"e12458","DOI":"10.1371\/journal.pone.0012458","article-title":"Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines","volume":"5","author":"Raghu","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.06.002_bib0135","first-page":"113","article-title":"The emerging role of MMP14 in brain tumorigenesis and future therapeutics","volume":"1846","author":"Ulasov","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2015.06.002_bib0140","first-page":"729","article-title":"Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy","volume":"34","author":"Ulasov","year":"2009","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2013.05.008","article-title":"Regulation of autophagy by stress-responsive transcription factors","volume":"23","author":"Pietrocola","year":"2013","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0150","first-page":"176","article-title":"Autophagy: an integral component of the mammalian stress response","volume":"1","author":"Ryter","year":"2013","journal-title":"J. Biochem. Pharmacol. Res"},{"key":"10.1016\/j.canlet.2015.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","article-title":"Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0165","doi-asserted-by":"crossref","first-page":"C383","DOI":"10.1152\/ajpcell.00164.2011","article-title":"Role of autophagy in angiogenesis in aortic endothelial cells","volume":"302","author":"Du","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2012.11.001","article-title":"Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method","volume":"35","author":"Kunkle","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.canlet.2015.06.002_bib0175","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-08-3255","article-title":"Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis","volume":"69","author":"Devy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.06.002_bib0180","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1242\/jcs.062711","article-title":"MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src","volume":"123","author":"Eisenach","year":"2010","journal-title":"J. Cell Sci"},{"key":"10.1016\/j.canlet.2015.06.002_bib0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1096\/fj.01-0790com","article-title":"MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression","volume":"16","author":"Sounni","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2015.06.002_bib0190","doi-asserted-by":"crossref","first-page":"e23902","DOI":"10.1371\/journal.pone.0023902","article-title":"Characteristics of the alternative phenotype of microglia\/macrophages and its modulation in experimental gliomas","volume":"6","author":"Gabrusiewicz","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.06.002_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2006.05.026","article-title":"Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells","volume":"542","author":"Trog","year":"2006","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.canlet.2015.06.002_bib0200","first-page":"435","article-title":"Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways","volume":"7","author":"Bancroft","year":"2001","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.06.002_bib0205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/gt.2012.42","article-title":"Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation","volume":"20","author":"Thaci","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gt.2008.3","article-title":"Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition","volume":"15","author":"Yoo","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.mt.6300023","article-title":"VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth","volume":"15","author":"Yoo","year":"2007","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0220","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.cgt.7700902","article-title":"Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region","volume":"13","author":"Saito","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0225","first-page":"1313","article-title":"E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model","volume":"2","author":"Zhou","year":"2003","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.canlet.2015.06.002_bib0230","first-page":"549","article-title":"Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma","volume":"27","author":"Arbab","year":"2012","journal-title":"Histol. Histopathol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515003821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515003821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T03:20:47Z","timestamp":1599103247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515003821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0304383515003821"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.06.002","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}